A
Ahmedin Jemal
Researcher at American Cancer Society
Publications - 568
Citations - 492750
Ahmedin Jemal is an academic researcher from American Cancer Society. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 132, co-authored 500 publications receiving 380474 citations. Previous affiliations of Ahmedin Jemal include Centers for Disease Control and Prevention & Emory University.
Papers
More filters
Journal ArticleDOI
The impact of the Patient Protection and Affordable Care Act on insurance coverage and cancer-directed treatment in HIV-infected patients with cancer in the United States.
Kelsey L. Corrigan,Leticia Nogueira,K. Robin Yabroff,Chun Chieh Lin,Chun Chieh Lin,Xuesong Han,Junzo Chino,Junzo Chino,Anna E. Coghill,Meredith S. Shiels,Ahmedin Jemal,Gita Suneja,Gita Suneja +12 more
TL;DR: The authors examined the effects of the ACA on insurance coverage and receipt of cancer treatment among people living with HIV and cancer in the United States.
Journal ArticleDOI
Economic loss attributable to cigarette smoking in the USA: an economic modelling study.
Nigar Nargis,A. K. M. Ghulam Hussain,Samuel Asare,Zheng Xue,Anuja Majmundar,Priti Bandi,Farhad Islami,K. Robin Yabroff,Ahmedin Jemal +8 more
TL;DR: In this paper , the authors used a dynamic macroeconomic model of personal income per capita at the state level to estimate the state-specific, annual, avoidable economic loss attributable to cigarette smoking in 2020 under the counterfactual 5% prevalence of cigarette smoking.
Journal ArticleDOI
Reaching 80% human papillomavirus vaccination prevalence by 2026: How many adolescents need to be vaccinated and what are their characteristics?
Stacey A. Fedewa,Alexander J. Preiss,Marcie Fisher-Borne,Ann Goding Sauer,Ahmedin Jemal,Debbie Saslow +5 more
TL;DR: The number of additional adolescents (11‐12 years old) who need HPVV for 80% prevalence to be reached by 2026 is estimated.
Journal ArticleDOI
Adequacy of Pathologic Reports of Invasive Breast Cancer From Mastectomy Specimens at Tikur Anbessa Specialized Hospital Oncology Center in Ethiopia.
Abdu A Yesufe,Mathewos Assefa,Abebe Bekele,Wondwossen Ergete,Abreha Aynalem,Tigeneh Wondemagegnehu,Johan Tausjø,Gizachew Assefa Tessema,Eva Johanna Kantelhardt,Ted Gansler,Ahmedin Jemal +10 more
TL;DR: No systematic evidence exists regarding the adequacy of breast pathology reporting in Ethiopia and quality measurement and improvement programs and capacity-building interventions by national pathology and oncology organizations, collaboration with medical and public health organizations in neighboring countries, adoption of synoptic reporting templates, use of electronic pathology reporting, and histotechnology and histopathology training collaborations with laboratories in high-resource regions are recommended.
Journal ArticleDOI
Assessment of Proton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004-2018
TL;DR: The findings of this study suggest that PBT uptake varies by indication group and is most commonly used to treat cancers for which PBT effectiveness is still under study.